Yonsei Med J.  2012 May;53(3):467-476. 10.3349/ymj.2012.53.3.467.

Cerebrovascular Disease and Stroke in Korean Male Adolescent

• Oh CH
• Chung J
• Hyun D
• Kim E
• Park H

• KMID: 1776979
• DOI: http://doi.org/10.3349/ymj.2012.53.3.467

Abstract

PURPOSE
This study aimed to estimate the prevalence and incidence of cerebrovascular disease (CVD) and stroke in Korean male adolescents.
MATERIALS AND METHODS
The authors reviewed all medical certificates, medical records, and radiologic images from the examinations of Korean military conscription from January 2008 to May 2011.
RESULTS
Of the 101156 examinees, 40 had CVD and stroke during adolescence. The overall prevalence and incidence of CVD and stroke was 39.54 cases per 100000 adolescents and 2.08 cases per 100000 adolescents per year, respectively and these were similar to the worldwide data. There were 3 cases of aneurysm, 3 cases of dural arteriovenous fistula, 11 cases of arteriovenous malformation, 4 cases of cavernous hemangioma, 4 cases of cerebrovascular infarction, 16 cases of Moyamoya disease, and 1 case of missing data. The incidence of arteriovenous malformation (0.57 cases per 100000 adolescents per year) was lower than the incidence for the worldwide general population. The incidence of Moyamoya disease was higher than that in any other country (15.82 cases per 100000 adolescents, vs. 0.83 cases per 100000 adolescents per year).
CONCLUSION
We observed ischemic and hemorrhagic stroke, each accounting for approximately half of cases, and high incidence of Moyamoya disease with low incidence of arteriovenous malformation in Korean male adolescents.

Keyword

Cerebrovascular disease; stroke; adolescent; male; Korea; conscription

MeSH Terms

Adolescent
Adult
Asian Continental Ancestry Group
Cerebrovascular Disorders/*epidemiology
Humans
Korea/epidemiology
Male
Moyamoya Disease/epidemiology
Stroke/*epidemiology
Young Adult

Reference

1. Zahuranec DB, Brown DL, Lisabeth LD, Morgenstern LB. Is it time for a large, collaborative study of pediatric stroke? Stroke. 2005. 36:1825–1829.

2. Lynch JK, Hirtz DG, DeVeber G, Nelson KB. Report of the National Institute of Neurological Disorders and Stroke workshop on perinatal and childhood stroke. Pediatrics. 2002. 109:116–123.

3. Earley CJ, Kittner SJ, Feeser BR, Gardner J, Epstein A, Wozniak MA, et al. Stroke in children and sickle-cell disease: Baltimore-Washington Cooperative Young Stroke Study. Neurology. 1998. 51:169–176.

4. Giroud M, Lemesle M, Gouyon JB, Nivelon JL, Milan C, Dumas R. Cerebrovascular disease in children under 16 years of age in the city of Dijon, France: a study of incidence and clinical features from 1985 to 1993. J Clin Epidemiol. 1995. 48:1343–1348.

5. Fullerton HJ, Wu YW, Sidney S, Johnston SC. Recurrent hemorrhagic stroke in children: a population-based cohort study. Stroke. 2007. 38:2658–2662.

6. Kurnik K, Kosch A, Sträter R, Schobess R, Heller C, Nowak-Göttl U. Childhood Stroke Study Group. Recurrent thromboembolism in infants and children suffering from symptomatic neonatal arterial stroke: a prospective follow-up study. Stroke. 2003. 34:2887–2892.

7. Ganesan V, Prengler M, McShane MA, Wade AM, Kirkham FJ. Investigation of risk factors in children with arterial ischemic stroke. Ann Neurol. 2003. 53:167–173.

8. deVeber G, Andrew M, Adams C, Bjornson B, Booth F, Buckley DJ, et al. Cerebral sinovenous thrombosis in children. N Engl J Med. 2001. 345:417–423.

9. Heller C, Heinecke A, Junker R, Knöfler R, Kosch A, Kurnik K, et al. Cerebral venous thrombosis in children: a multifactorial origin. Circulation. 2003. 108:1362–1367.

10. Sébire G, Tabarki B, Saunders DE, Leroy I, Liesner R, Saint-Martin C, et al. Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome. Brain. 2005. 128(Pt 3):477–489.

11. Shellhaas RA, Smith SE, O'Tool E, Licht DJ, Ichord RN. Mimics of childhood stroke: characteristics of a prospective cohort. Pediatrics. 2006. 118:704–709.

12. Pappachan J, Kirkham FJ. Cerebrovascular disease and stroke. Arch Dis Child. 2008. 93:890–898.

13. Kwon SU, Kim JS, Lee JH, Lee MC. Ischemic stroke in Korean young adults. Acta Neurol Scand. 2000. 101:19–24.

14. Schoenberg BS, Mellinger JF, Schoenberg DG. Cerebrovascular disease in infants and children: a study of incidence, clinical features, and survival. Neurology. 1978. 28:763–768.

15. Broderick J, Talbot GT, Prenger E, Leach A, Brott T. Stroke in children within a major metropolitan area: the surprising importance of intracerebral hemorrhage. J Child Neurol. 1993. 8:250–255.

16. Lynch JK. The hospitalization of childhood stroke in the United States, 1979-2000 [poster presentation, abstract]. Stroke. 2003. 34:287.

17. Fullerton HJ, Wu YW, Zhao S, Johnston SC. Risk of stroke in children: ethnic and gender disparities. Neurology. 2003. 61:189–194.

18. Eeg-Olofsson O, Ringheim Y. Stroke in children. Clinical characteristics and prognosis. Acta Paediatr Scand. 1983. 72:391–395.

19. Visudhiphan P, Chiemchanya S, Wattanasirichaigoon D. Strokes in Thai children: etiology and outcome. Southeast Asian J Trop Med Public Health. 1996. 27:801–805.

20. Giroud M, Lemesle M, Madinier G, Manceau E, Osseby GV, Dumas R. Stroke in children under 16 years of age. Clinical and etiological difference with adults. Acta Neurol Scand. 1997. 96:401–406.

21. Lin CL, Loh JK, Kwan AL, Howng SL. Spontaneous intracerebral hemorrhage in children. Kaohsiung J Med Sci. 1999. 15:146–151.

22. Lanthier S, Carmant L, David M, Larbrisseau A, de Veber G. Stroke in children: the coexistence of multiple risk factors predicts poor outcome. Neurology. 2000. 54:371–378.

23. Blom I, De Schryver EL, Kappelle LJ, Rinkel GJ, Jennekens-Schinkel A, Peters AC. Prognosis of haemorrhagic stroke in childhood: a long-term follow-up study. Dev Med Child Neurol. 2003. 45:233–239.

24. Meyer-Heim AD, Boltshauser E. Spontaneous intracranial haemorrhage in children: aetiology, presentation and outcome. Brain Dev. 2003. 25:416–421.

25. Liu AC, Segaren N, Cox TS, Hayward RD, Chong WK, Ganesan V, et al. Is there a role for magnetic resonance imaging in the evaluation of non-traumatic intraparenchymal haemorrhage in children? Pediatr Radiol. 2006. 36:940–946.

26. Norris JS, Wallace MC. Pediatric intracranial aneurysms. Neurosurg Clin N Am. 1998. 9:557–563.

27. Wani AA, Phadke R, Behari S, Sahu R, Jaiswal A, Jain V. Role of diffusion-weighted MRG in predicting outcome in subarachnoid hemorrhage due to anterior communicating artery aneurysms. Turk Neurosurg. 2008. 18:10–16.

28. Kapoor K, Kak VK. Incidence of intracranial aneurysms in north-west Indian population. Neurol India. 2003. 51:22–26.

29. Osborn AG, Blaser SI, Salzman KL, Katzman GL, Provenzale J, Castillo M. Diagnostic imaging brain. 2004. Salt Lake City (Utah): Amirsys, Inc.

30. Kwon TH, Moon SH, Lim DJ, Park YK, Chung HS, Lee HK, et al. Intracranial aneurysm associated with moyamoya disease. J Korean Neurosurg Soc. 1999. 28:1661–1665.

31. Hourihan MD, Gates PC, McAllister VL. Subarachnoid hemorrhage in childhood and adolescence. J Neurosurg. 1984. 60:1163–1166.

32. Meyer FB, Sundt TM Jr, Fode NC, Morgan MK, Forbes GS, Mellinger JF. Cerebral aneurysms in childhood and adolescence. J Neurosurg. 1989. 70:420–425.

33. Brown RD Jr, Wiebers DO, Torner JC, O'Fallon WM. Frequency of intracranial hemorrhage as a presenting symptom and subtype analysis: a population-based study of intracranial vascular malformations in Olmsted Country, Minnesota. J Neurosurg. 1996. 85:29–32.

34. Mohe JP, Pile-Spellman J, Stein BM. Barnett JM, Mohr JP, Stein BM. Arteriovenous malformations and other vascular anomalies. Stroke, Pathophysiology, Diagnosis, and Management. 1998. 3rd ed. Philadephia: Churchill Livingstone;725–750.

35. Stapf C, Mohr JP, Pile-Spellman J, Solomon RA, Sacco RL, Connolly ES Jr. Epidemiology and natural history of arteriovenous malformations. Neurosurg Focus. 2001. 11:e1.

36. Kondziolka D, McLaughlin MR, Kestle JR. Simple risk predictions for arteriovenous malformation hemorrhage. Neurosurgery. 1995. 37:851–855.

37. Otten P, Pizzolato GP, Rilliet B, Berney J. [131 cases of cavernous angioma (cavernomas) of the CNS, discovered by retrospective analysis of 24,535 autopsies]. Neurochirurgie. 1989. 35:82–83. 128–131.

38. Kim DS, Park YG, Choi JU, Chung SS, Lee KC. An analysis of the natural history of cavernous malformations. Surg Neurol. 1997. 48:9–17.

39. Sage MR, Brophy BP, Sweeney C, Phipps S, Perrett LV, Sandhu A, et al. Cavernous haemangiomas (angiomas) of the brain: clinically significant lesions. Australas Radiol. 1993. 37:147–155.

40. Sträter R, Becker S, von Eckardstein A, Heinecke A, Gutsche S, Junker R, et al. Prospective assessment of risk factors for recurrent stroke during childhood--a 5-year follow-up study. Lancet. 2002. 360:1540–1545.

41. Kirkham FJ, Prengler M, Hewes DK, Ganesan V. Risk factors for arterial ischemic stroke in children. J Child Neurol. 2000. 15:299–307.

42. Suzuki J, Takaku A. Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969. 20:288–299.

43. Kuriyama S, Kusaka Y, Fujimura M, Wakai K, Tamakoshi A, Hashimoto S, et al. Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey. Stroke. 2008. 39:42–47.

44. Ikezaki K, Han DH, Kawano T, Kinukawa N, Fukui M. A clinical comparison of definite moyamoya disease between South Korea and Japan. Stroke. 1997. 28:2513–2517.

45. Burke GM, Burke AM, Sherma AK, Hurley MC, Batjer HH, Bendok BR. Moyamoya disease: a summary. Neurosurg Focus. 2009. 26:E11.

46. Kelly ME, Bell-Stephens TE, Marks MP, Do HM, Steinberg GK. Progression of unilateral moyamoya disease: a clinical series. Cerebrovasc Dis. 2006. 22:109–115.

47. Baba T, Houkin K, Kuroda S. Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry. 2008. 79:900–904.

48. Wakai K, Tamakoshi A, Ikezaki K, Fukui M, Kawamura T, Aoki R, et al. Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey. Clin Neurol Neurosurg. 1997. 99:Suppl 2. S1–S5.

49. Su CF, Shih CJ, Lin LS, Hung TP. [Moyamoya disease in Taiwan]. J Formos Med Assoc. 1994. 93:Suppl 2. S90–S97.

50. Choi SK, Kim GK, Kim HD, Lim YJ, Kim TS, Rhee BA, et al. Natural history of moyamoya disease. J Korean Neurosurg Soc. 1995. 24:536–545.

51. Marcinkevicius E, Liutkus D, Gvazdaitis A. Experience of treatment of moyamoya disease at the Clinic of Neurosurgery of Kaunas University of Medicine. Medicina (Kaunas). 2006. 42:130–136.

52. Kraemer M, Heienbrok W, Berlit P. Moyamoya disease in Europeans. Stroke. 2008. 39:3193–3200.

53. Shoukat S, Itrat A, Taqui AM, Zaidi M, Kamal AK. Moyamoya disease: a clinical spectrum, literature review and case series from a tertiary care hospital in Pakistan. BMC Neurol. 2009. 9:15.